Passage Bio (NYSE:GFL) Earns Outperform Rating from Analysts at Raymond James

Raymond James started coverage on shares of Passage Bio (NYSE:GFL) in a report released on Monday morning, The Fly reports. The brokerage issued an outperform rating and a $18.00 price objective on the stock.

GFL has been the subject of a number of other reports. Barclays initiated coverage on shares of Passage Bio in a report on Monday. They issued an equal weight rating and a $20.00 price target for the company. CIBC initiated coverage on shares of Passage Bio in a report on Monday. They issued a neutral rating and a $27.00 price target for the company. Goldman Sachs Group initiated coverage on shares of Passage Bio in a report on Monday. They issued a neutral rating for the company. Stifel Nicolaus initiated coverage on shares of Passage Bio in a report on Monday. They issued a buy rating and a $26.00 price target for the company. Finally, Scotiabank initiated coverage on shares of Passage Bio in a report on Monday. They issued an outperform rating and a $23.00 price target for the company. Four research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. Passage Bio has a consensus rating of Buy and an average price target of $21.38.

GFL stock traded down $0.60 during trading on Monday, hitting $13.14. The company had a trading volume of 1,366,400 shares, compared to its average volume of 2,322,005. Passage Bio has a fifty-two week low of $13.00 and a fifty-two week high of $17.95.

Passage Bio Company Profile

GFL Environmental Inc operates as a diversified environmental services company in North America. The company offers non-hazardous solid waste management, infrastructure and soil remediation, and liquid waste management services. Its solid waste management business line includes the collection, transportation, transfer, recycling, and disposal of non-hazardous solid waste for municipal, residential, and commercial and industrial customers.

Read More: Range Trading

The Fly

Analyst Recommendations for Passage Bio (NYSE:GFL)

Receive News & Ratings for Passage Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Passage Bio and related companies with MarketBeat.com's FREE daily email newsletter.